Medigene AG
MediGene AG english
MediGene AG
Ad-hoc-announcement processed and transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
MediGene announces appeal in dispute with Loyola University, Chicago and
MedImmune, Inc.
Martinsried / San Diego, March 26, 2002. MediGene AG (Neuer Markt: MDG), the
German-U.S. biotech company listed on the Neuer Markt at the Frankfurt Stock
Exchange, announced today that it will appeal the final judgement entered by
the United States District Court in Chicago in its dispute with Loyola
University of Chicago, MedImmune Inc. and an individual defendant relating to
ownership of the CVLP technology. The CVLP technology is a method for creation
of virus-like particles that may potentially be used to treat certain HPV-
induced tumors. The judgment rejected each of MediGene’s ownership claims to
disputed patents, as the court had announced preliminarily it would do a year
ago (see ad hoc publication of MediGene from March 23, 2001). In the judgment
the court also granted Loyola’s first counterclaim against MediGene, ordering
MediGene to transfer certain disputed rights to Loyola. Proceedings on further
counterclaims by Loyola and MedImmune, Inc. were deferred pending the outcome
of MediGene’s appeal. A CVLP technology based tumor vaccine for the treatment
of cervical cancer and its precursors is one of MediGene’s seven clinical
product candidate programs.
For further information please contact:
MediGene AG email: investor@medigene.com
fax: ++49 – 89 – 89 56 32-20
Julia Hofmann, Public Relations phone: ++49 – 89 – 89 56 32-16
Michael Nettersheim, Investor Relations phone: ++49 – 89 – 89 56 32-46
end of ad-hoc-announcement (c)DGAP 26.03.2002
——————————————————————————–
WKN: 502090; ISIN: DE0005020903; Index: NEMAX- 50
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
260800 Mär 02
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden